-
Loading metrics
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
-
Pierre Bories ,
Roles Conceptualization, Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing
* E-mail: pierre.bories@onco-occitanie.fr
Affiliations Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France, Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France, Réseau Onco-occitanie, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⨯ - Naïs Prade,
- Stéphanie Lagarde,
- Bastien Cabarrou,
- Laetitia Largeaud,
- Julien Plenecassagnes,
- Isabelle Luquet,
- Véronique De Mas,
- Thomas Filleron,
- Manon Cassou,
- Audrey Sarry,
- Luc-Matthieu Fornecker,
- Célestine Simand,
- Sarah Bertoli,
- Christian Recher,
- [ ... ],
- Eric Delabesse
- [ view all ]
- [ view less ]
http://orcid.org/0000-0002-2252-0395
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
- Pierre Bories,
- Naïs Prade,
- Stéphanie Lagarde,
- Bastien Cabarrou,
- Laetitia Largeaud,
- Julien Plenecassagnes,
- Isabelle Luquet,
- Véronique De Mas,
- Thomas Filleron,
- Manon Cassou
x
- Published: October 1, 2020
- https://doi.org/10.1371/journal.pone.0238795